Purdue Pharma LLP
Based in DC
🤖
AI Overview
With $1.7M in lobbying spend across 34 quarterly filings, Purdue Pharma LLP is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2018 to 2025.
$1.7M
Total Spend
8
Years Active
1
Firms Hired
6
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $250K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $250K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Medicare/Medicaid, Budget/Appropriations, Banking
- •Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act;
- •Controlled Drug Substances Act (21 USC 13)
- •General Medicare and Medicaid issues including, but not limited to, coverage reimbursement, payments and rebates
- •Issues related to Labor-HHS funding. Issues related to funding of the 21st Century Cures Act.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Follow the Money
Tracking lobbying dollars through the financial system.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Association of Benefits and Insurance Professionals
$8.6M total spend
F Hoffmann-la Roche LTD and its Affiliates
$4.0M total spend
Biotechnology Industry Organization
$2.8M total spend
The Campaign for Sustainable Rx Pricing
$2.6M total spend
National Organization for Rare Disorders INC (Nord)
$2.1M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.